Bright Green Corporation (BGXXQ) vs InMed Pharmaceuticals Inc. (INM)

Bright Green Corporation and InMed Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Bright Green Corporation is the larger, with a market value of $13.9M against $7.3M — 1.9× the size. Across the 10 metrics below, Bright Green Corporation leads on 5 and InMed Pharmaceuticals Inc. on 5.

Valuation

Metric BGXXQ INM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S n/m 0.95 2.11
P/B n/m 5.11 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales n/m 0.58 2.73
Earnings yield 0.00% (228.36%) (4.38%)
Free cash flow yield 0.00% (158.00%) 0.00%

Profitability

Metric BGXXQ INM Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 26.27% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (73.60%) (179.09%) (0.40%)
Return on assets (44.80%) (139.63%) (3.32%)
Return on invested capital (39.35%) 0.00% 0.00%

Growth

Metric BGXXQ INM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 19.38% 10.01%
EPS growth (last fiscal year) 58.82% 62.68% 49.06%
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BGXXQ INM Drug Manufacturers Specialty & Generic median
Debt to equity 0.07 0.00 0.05
Current ratio 0.01 1.37 2.31
Net debt to EBITDA (0.02) 0.20 0.97

Dividend

Metric BGXXQ INM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BGXXQ INM Drug Manufacturers Specialty & Generic median
Market cap 13.88m 7.31m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack